QQ客服 官方微博 反馈留言

	Cetuximab combined with concurrent chemoradiotheray in Chinese patients with unresectable, locally advanced esophageal squamous cell carcinoma: A prospective, multicenter phase II trial.
	Meng, Xue; Wang, Jianhua; Sun, Xindong; Wang, Lvhua; Ye, Ming; Feng, Ping Bo; Zhu, Guangying; Lu, You; Han, Chun; Zhu, Shu Chai
	2013
卷号	31期号:15
ISSN号	0732-183X
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6687789
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Meng, Xue,Wang, Jianhua,Sun, Xindong,et al. Cetuximab combined with concurrent chemoradiotheray in Chinese patients with unresectable, locally advanced esophageal squamous cell carcinoma: A prospective, multicenter phase II trial.[J],2013,31(15).
APA	Meng, Xue.,Wang, Jianhua.,Sun, Xindong.,Wang, Lvhua.,Ye, Ming.,...&Yu, Jinming.(2013).Cetuximab combined with concurrent chemoradiotheray in Chinese patients with unresectable, locally advanced esophageal squamous cell carcinoma: A prospective, multicenter phase II trial..,31(15).
MLA	Meng, Xue,et al."Cetuximab combined with concurrent chemoradiotheray in Chinese patients with unresectable, locally advanced esophageal squamous cell carcinoma: A prospective, multicenter phase II trial.".31.15(2013).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。